The pharmacokinetics of cerivastatin in patients on chronic hemodialysis.
- 1 May 2001
- journal article
- clinical trial
- Published by Dustri-Verlag Dr. Karl Feistle in Int. Journal of Clinical Pharmacology and Therapeutics
- Vol. 39 (5) , 192-198
- https://doi.org/10.5414/cpp39192
Abstract
The single-dose and steady-state pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin and its two major metabolites, M-1 and M-23, were evaluated in patients with renal failure on chronic hemodialysis.Keywords
This publication has 0 references indexed in Scilit: